CD137 Polyclonal Antibody

CD137 Polyclonal Antibody

The CD137 polyclonal antibody is a highly specific and sensitive tool used in various research applications. This antibody is designed to target and bind to the CD137 protein, also known as 4-1BB, which is a member of the tumor necrosis factor receptor superfamily. CD137 is primarily expressed on activated T cells, natural killer cells, and dendritic cells, playing a crucial role in immune responses and regulation.

This polyclonal antibody is produced by immunizing animals with a recombinant CD137 protein, ensuring high affinity and specificity for the target antigen. It has been extensively validated for use in various experimental techniques, including Western blotting, immunohistochemistry, flow cytometry, and immunofluorescence. The antibody exhibits excellent performance in detecting CD137 expression in both human and animal tissues, making it a versatile tool for researchers in the field of immunology and cancer biology.

The CD137 polyclonal antibody offers several advantages over other antibodies available in the market. Its high sensitivity allows for the detection of low levels of CD137 expression, enabling researchers to study the dynamics of CD137 signaling pathways in different cell types and disease models. Additionally, this antibody demonstrates minimal cross-reactivity with other related proteins, ensuring accurate and reliable results. With its exceptional performance and broad applicability, the CD137 polyclonal antibody is an indispensable tool for investigating the role of CD137 in immune responses, cancer immunotherapy, and other related fields.